David Drutz, Director at Altimmune, Inc. (ALT), bought 1,000 shares at $8.00 ($8K) on 2022-06-15, disclosed to the SEC on 2022-06-16.
Open-market purchase of $8k ALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ALT | BUY | 2023-03-27 | $38K | — | Filing → |
| ALT | BUY | 2022-05-25 | $5K | — | Filing → |
| ALT | BUY | 2017-08-24 | $22K | — | Filing → |